Inhibrx Biosciences Inc (INBX)
$71.78 -2.54% Close Oct 30, 2026 Live
Inhibrx Biosciences stock today
Inhibrx Biosciences closed at $71.78 on October 30, 2026, down 2.54% on the day. Over the past year it returned -8.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.05 billion.
$75.00$100.00$125.00
NovJan 2026MarMayJulSep
| Period | INBX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -28.3% | -0.9% |
| 3 months | -15.3% | +2.1% |
| Year to date | -9.1% | +11.7% |
| 1 year | -8.6% | +12.4% |
Key statistics
- Market value
- $1.05B
- 52-week range
- $58.39 to $141.84
- Next report
- Nov 13, 2026
About Inhibrx Biosciences
Develops monoclonal antibody therapeutics for oncology and other diseases.
Sector: Health Care
More on Inhibrx Biosciences
- Financials: revenue, earnings and segmentsRevenue +550% in the year to Dec 2025
- Returns: what $1,000 became$1,000 one year ago is $914.28 today
No forecast, no recommendation. This page describes Inhibrx Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.